Clinical trial
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of a Single Oral Dose of Zoliflodacin 3 g on Testicular Function in Healthy Adult Men
NCT07640477 is registered in ClinicalTrials.gov with Global Antibiotics Research and Development Partnership as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of a Single Oral Dose of Zoliflodacin 3 g on Testicular Function in Healthy Adult Men
- Lead sponsor
- Global Antibiotics Research and Development Partnership
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- October 31, 2026
- Completion date
- November 30, 2027
- Enrollment
- 200 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
testicular abnominalies